BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2499541)

  • 1. Clearance of Cryptococcus neoformans from immunologically suppressed mice.
    Murphy JW
    Infect Immun; 1989 Jul; 57(7):1946-52. PubMed ID: 2499541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine.
    Lambros MP; Schafer F; Blackstock R; Murphy JW
    J Pharm Sci; 1998 Sep; 87(9):1144-8. PubMed ID: 9724568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans.
    Doyle HA; Murphy JW
    J Leukoc Biol; 1997 Feb; 61(2):147-55. PubMed ID: 9021919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.
    Buchanan KL; Murphy JW
    Infect Immun; 1993 Jul; 61(7):2854-65. PubMed ID: 8514388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.
    Murphy JW; Cox RA
    Clin Exp Immunol; 1988 Aug; 73(2):174-80. PubMed ID: 2460273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).
    Khakpour FR; Murphy JW
    Infect Immun; 1987 Jul; 55(7):1657-62. PubMed ID: 2954914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.
    Lim TS; Murphy JW; Cauley LK
    Infect Immun; 1980 Aug; 29(2):633-41. PubMed ID: 7011980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity in a cutaneous model of cryptococcosis.
    Domer JE; Lyon FL; Murphy JW
    Infect Immun; 1983 Jun; 40(3):1052-9. PubMed ID: 6343238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.
    Murphy JW; Mosley RL; Moorhead JW
    J Immunol; 1983 Jun; 130(6):2876-81. PubMed ID: 6222119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response.
    Fidel PL; Murphy JW
    Infect Immun; 1990 Feb; 58(2):393-8. PubMed ID: 2105273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.
    Murphy JW; Schafer F; Casadevall A; Adesina A
    Infect Immun; 1998 Jun; 66(6):2632-9. PubMed ID: 9596727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity.
    Murphy JW
    Infect Immun; 1985 May; 48(2):439-45. PubMed ID: 3157646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.
    Mosley RL; Murphy JW; Cox RA
    Infect Immun; 1986 Mar; 51(3):844-50. PubMed ID: 2936685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.
    Blackstock R; Murphy JW
    Infect Immun; 2004 Sep; 72(9):5175-80. PubMed ID: 15322012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Mar; 63(3):770-8. PubMed ID: 7868246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.
    Mandel MA; Grace GG; Orsborn KI; Schafer F; Murphy JW; Orbach MJ; Galgiani JN
    Infect Immun; 2000 Nov; 68(11):6196-201. PubMed ID: 11035725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Cryptococcus neoformans-specific suppressor T cells on the amplified anticryptococcal delayed-type hypersensitivity response.
    Buchanan KL; Fidel PL; Murphy JW
    Infect Immun; 1991 Jan; 59(1):29-35. PubMed ID: 1824761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response.
    McGaha T; Murphy JW
    Infect Immun; 2000 Aug; 68(8):4624-30. PubMed ID: 10899865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.